Evidence map›Paper›PMID 26291453›Full record

ArticlePloS one2015

Role for Rab10 in Methamphetamine-Induced Behavior.

Scott M Vanderwerf, David C Buck, Phillip A Wilmarth, Leila M Sears, Larry L David, David B Morton, Kim A Neve

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Bitter Sensing ProtectsThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  2. Article
  3. The CaMKII-dependent phosphorylation of GABACNS neuroscience & therapeutics · 2023
    Article
  4. The Use ofBiomedicines · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. A Fly's Eye View of Natural and Drug Reward.Frontiers in physiology · 2018
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Scott M VanderwerfDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon, United States of America; Department of Integrative Biosciences, Oregon Health & Science University, Portland, Oregon, United States of America.
David C BuckDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon, United States of America.
Phillip A WilmarthDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, United States of America.
Leila M SearsDepartment of Integrative Biosciences, Oregon Health & Science University, Portland, Oregon, United States of America.
Larry L DavidDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, United States of America.
David B MortonDepartment of Integrative Biosciences, Oregon Health & Science University, Portland, Oregon, United States of America.
Kim A NeveDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon, United States of America; Research Service, VA Portland Health Care System, Portland, Oregon, United States of America.
Oregon Health & Science University · USVA Portland Health Care System · US

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Grace B Gill · 1997 to 2026
$60.5M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
Regulation and Function of cGMP in the nervous systemR01GM105396 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MORTON, DAVID B · 2012 to 2015
$1.2M
BLRD VA I01 BX000810NCI NIH HHS P30 CA069533NCI NIH HHS P30CA069533NEI NIH HHS P30 EY010572NEI NIH HHS P30EY010572NIGMS NIH HHS R01 GM105396NIGMS NIH HHS R01GM105396
6 · The paper itself

Abstract

Lipid rafts are specialized, cholesterol-rich membrane compartments that help to organize transmembrane signaling by restricting or promoting interactions with subsets of the cellular proteome. The hypothesis driving this study was that identifying proteins whose relative abundance in rafts is altered by the abused psychostimulant methamphetamine would contribute to fully describing the pathways involved in acute and chronic effects of the drug. Using a detergent-free method for preparing rafts from rat brain striatal membranes, we identified density gradient fractions enriched in the raft protein flotillin but deficient in calnexin and the transferrin receptor, markers of non-raft membranes. Dopamine D1- and D2-like receptor binding activity was highly enriched in the raft fractions, but pretreating rats with methamphetamine (2 mg/kg) once or repeatedly for 11 days did not alter the distribution of the receptors. LC-MS analysis of the protein composition of raft fractions from rats treated once with methamphetamine or saline identified methamphetamine-induced changes in the relative abundance of 23 raft proteins, including the monomeric GTP-binding protein Rab10, whose abundance in rafts was decreased 2.1-fold by acute methamphetamine treatment. Decreased raft localization was associated with a selective decrease in the abundance of Rab10 in a membrane fraction that includes synaptic vesicles and endosomes. Inhibiting Rab10 activity by pan-neuronal expression of a dominant-negative Rab10 mutant in Drosophila melanogaster decreased methamphetamine-induced activity and mortality and decreased caffeine-stimulated activity but not mortality, whereas inhibiting Rab10 activity selectively in cholinergic neurons had no effect. These results suggest that activation and redistribution of Rab10 is critical for some of the behavioral effects of psychostimulants.

Indexed as

AnimalsBrainDopamine Uptake InhibitorsDrosophila melanogasterDrosophila ProteinsMaleMembrane MicrodomainsMethamphetamineMonomeric GTP-Binding ProteinsMutationrab GTP-Binding ProteinsRats, Sprague-DawleyReceptors, DopamineDopamine Uptake InhibitorsDrosophila ProteinsMethamphetamineMonomeric GTP-Binding ProteinsRab10 protein, DrosophilaRab10 protein, ratrab GTP-Binding ProteinsReceptors, Dopamine

Identifiers

PMID26291453
PMCPMC4546301
OpenAlexW1623372018

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.